Work

Improved Cognitive Outcomes in Relapsing-Remitting Multiple Sclerosis with Daclizumab HYP Over 96 Weeks in the Phase 3 DECIDE Study (P3.090)

Year: 2016

Type: article

Source: Neurology

DOI: 10.1212/wnl.86.16_supplement.p3.090

Authors: Ralph Benedict, Stanley Cohan, Sharon Lynch, Steven Greenberg, Ping Wang, Jacob Elkins, Guido Sabatella

Institutions: University at Buffalo, State University of New York, University of Kansas Medical Center, AbbVie (United States), Biogen (United States)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2487043345

FWCI: 1.046

Cites:

Cited by: 8

Related to: 10